GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order HHSN27200005ADVANCED BIOSCIENCE LABORATORIES, INC.

Overview

Award facts

Net obligations
$9.97M
$9,967,500of $9.97M potential value
Outlays (paid to date)
$340.24K
$340.24K paid of $9.97M obligated$340,238
Period of performance
Sep 27, 2012 to Jul 31, 2025
Ended
Modifications
11
Latest action Jun 6, 2025
Contract type
Delivery order
PIID HHSN27200005

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF - NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF THE MHRP GP145 CLADE C TRIMER PROTEIN

Dates and value

Award date
Signed on Sep 25, 2012
Potential end of performance
Jul 30, 2025
Current value
$9,967,500Base and exercised options
Potential value (if all options are exercised)
$9,967,500
Parent contract vehicle
HHSN272201100021I (IDC, single award) — 37 orders recorded under it

Obligations by fiscal year of action

  • FY2025: $25,135
  • FY2022: $254,278
  • FY2020: $92,245
  • FY2017: $479,765
  • FY2016: $67,221
  • FY2015: $998,870
  • FY2014: $1,117,336
  • FY2013: $1,136,533
Show all 9 years
  • FY2012: $5,796,117

Total across 9 fiscal years: $9,967,500

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 6, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NameADVANCED BIOSCIENCE LABORATORIES, INC.
LocationROCKVILLE, MD
UEIMK4QC9EKZXG8
CAGE code4KCY8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCOMPAGNIE MERIEUX ALLIANCE

Business types and certifications

Foreign-ownedFor-profit organizationCorporation (not tax-exempt)Manufacturer of goods

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Rockville, Montgomery County, Maryland 20850-3770
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

NAICS
541712RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
Product or service (PSC)
AN86R&D- MEDICAL: AIDS RESEARCH (MANAGEMENT/SUPPORT) (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
1

Contract details

Subcontracting plan
Plan required - incentive not includedC
Major program
Niaid preclinical development support - production of the mhrp gp145 clade c trimer protein
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 25, 2012Base obligation at award: $5,796,117
Latest action
Jun 6, 2025 — Funding onlyModification P00011; obligation change +$25,135; funding only: changes obligations, not scope
Latest substantive action
Jun 22, 2022 — Change order definitizedModification P00010; obligation change +$254,278
Latest funding action
Jun 6, 2025 — Funding onlyModification P00011; obligation change +$25,135; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only4
  • Change order4
  • Other administrative action2
  • Change order definitized1
12 actions recorded, Sep 25, 2012 to Jun 6, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$25,135
Latest action: change in base and all options
$25,135

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Single awardS
Parent vehicle agency
National Institutes Of Health7529
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
12

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2020/2020-0885-000
  • 075-2022/2022-0885-000
  • 075-2025/2025-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression